FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 4111907 · Received September 23, 2014

Report

Report Number
1416980-2014-32909
Event Type
Injury
Date Received
September 23, 2014
Report Date
August 29, 2014
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE REPORTED PRODUCT IS AN UNKNOWN BAXTER TRANSFER SET. THE PATIENT WAS REPORTED TO HAVE EXPERIENCED PERITONITIS ON AN UNREPORTED DATE IN (B)(6) 2014. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. THIS REPORT INVOLVES THE SAME PATIENT AS IN (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS COINCIDENT WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) THERAPY. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. IN THE SAME MONTH AS ONSET, THE PATIENT WAS HOSPITALIZED FOR THE PERITONITIS. THE PATIENT WAS TREATED WITH CEFAZOLINE (INTRAPERITONEALLY, DOSE AND FREQUENCY NOT REPORTED), TOBRAMYCIN (INTRAPERITONEALLY, DOSE AND FREQUENCY NOT REPORTED) AND INJECTION CEZIME (INTRAVENOUS, DOSE AND FREQUENCY NOT REPORTED) FOR THE EVENT. TREATMENT WITH CEFAZOLINE AND TOBRAMYCIN WERE LATER DISCONTINUED AND CEZIME THERAPY WAS ONGOING. AT THE TIME OF THIS REPORT THE PATIENT WAS STILL HOSPITALIZED AND HAD NOT RECOVERED FROM THE EVENT. CAPD THERAPY WAS DISCONTINUED. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE. THIS IS REPORT 1 OF 3 INVOLVED IN THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
590788 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R MINICAP, TITANIUM ADAPTER| DIANEAL AND EXTRANEAL